Crossix Solutions and 4INFO to Explore Breakthrough Approach to Mobile Hypertargeting at DTC National

Session will delve into a pharma case study that highlights how a brand used innovative analytics to reach a qualified mobile audience programmatically

NEW YORK, NY – April 6, 2016 – Shannon Gallagher, VP of Analytics Services at Crossix and Chris Colella, Director of Pharmaceutical Business at 4INFO will speak at this year’s DTC National Conference on Wednesday, April 20, 2016. The conference is being held at the Sheraton Boston in Boston, MA. 

According to Pew Research Center, 62% of smartphone owners have used their phone to look up health information. It should be no surprise then that healthcare marketers are seeking new and better ways to reach relevant health audiences on mobile devices. This case study explores just that – how an actual pharma brand leveraged predictive data to reach qualified audiences on their mobile devices with greater efficiency and drive impact efficiently with targeted scale.

“I'm excited to join 4INFO on stage to bring this exciting approach to light. Mobile is becoming a much greater part of the media mix, making proven methods of targeting and measurement increasingly valuable.”
- Shannon Gallagher, VP, Analytics Services at Crossix

The presentation will be held from 3:30-4:00pm EDT. For those unable to attend in person, a PDF version of the presentation can be shared upon request.

To learn more about our mobile audience and analytics solutions or our upcoming speaking sessions, contact us

About Crossix Solutions

Crossix partners with leading healthcare and media companies to plan, measure and optimize their marketing and communication initiatives. With deep consumer and healthcare professional (HCP) expertise, Crossix delivers hard-to-come-by audience and campaign insights to inform strategic business decisions and drive improved patient outcomes. Data-driven and data-proven, the patented Crossix methodology and differentiated technology enable critical connections across its proprietary data network of Rx, OTC, medical, clinical, media and consumer data to ensure more actionable cross-channel measurement with best-in-class privacy safeguards far exceeding HIPAA requirements. The unique Crossix technology aggregates insights from across the data network to pinpoint marketing initiatives that activate the right audiences and generate incremental impact. Founded in 2004, Crossix is headquartered in New York City. 

Media Contact
Bridget McGahen